Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. The company was started in 2022.

&lt;div class=&quot;content-intro&quot;&gt;&lt;h2&gt;&lt;strong&gt;Our Mission&lt;/strong&gt;&lt;/h2&gt;
&lt;p&gt;Our mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life.&lt;/p&gt;
&lt;p&gt;For more information, see our website at &lt;a href=&quot;https://altoslabs.com/&quot; target=&quot;_blank&quot;&gt;altoslabs.com.&lt;/a&gt;&lt;/p&gt;
&lt;h2&gt;&lt;strong&gt;Our Value&lt;/strong&gt;&lt;/h2&gt;
&lt;p&gt;Our Single Altos Value: &lt;strong&gt;Everyone Owns Achieving Our Inspiring Mission&lt;/strong&gt;.&lt;/p&gt;
&lt;h2&gt;&lt;strong&gt;Diversity at Altos&lt;/strong&gt;&lt;/h2&gt;
&lt;p&gt;We believe that diverse perspectives are foundational to scientific innovation and inquiry. At Altos, exceptional scientists and industry leaders from around the world work together to advance a shared mission. Our intentional focus is on Belonging, so that all employees know that they are valued for their unique perspectives. We are all accountable for sustaining a diverse and inclusive environment.&lt;/p&gt;&lt;/div&gt;&lt;h2&gt;Don&#39;t see a position that interests you? Drop your resume!&lt;/h2&gt;
&lt;p&gt;Thank you for your interest in Altos Labs! Please drop your resume here if you did not discover a job you are interested in applying for. Your profile will be added to our system and we will consider you for future job opportunities if we think you are a good fit for a position.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;In the meantime, be sure to regularly check our job board -- we&#39;re posting new jobs every week.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Before submitting your application:&lt;/p&gt;
&lt;p&gt;- Please click here to read the Altos Labs EU and UK Applicant Privacy Notice (&lt;a class=&quot;orb-typography link-card__info-container__short-url&quot; href=&quot;https://bit.ly/eu_uk_privacy_notice&quot; target=&quot;_blank&quot;&gt;bit.ly/eu_uk_privacy_notice&lt;/a&gt;)&lt;br&gt;- This Privacy Notice is not a contract, express or implied and it does not set terms or conditions of employment.&lt;/p&gt;&lt;div class=&quot;content-conclusion&quot;&gt;&lt;h2&gt;&lt;strong&gt;What We Want You To Know&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/h2&gt;
&lt;p&gt;We are a culture of collaboration and scientific excellence, and we believe in the values of inclusion and belonging to inspire innovation.&lt;/p&gt;
&lt;p&gt;&lt;span style=&quot;font-weight: 400;&quot;&gt;Altos Labs provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style=&quot;font-weight: 400;&quot;&gt;This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Altos currently requires all employees to be fully vaccinated against COVID-19, subject to legally required exemptions (e.g., due to a medical condition or sincerely-held religious belief).&lt;/p&gt;
&lt;p&gt;Thank you for your interest in Altos Labs where we strive for a culture of scientific excellence, learning, and belonging.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Note: Altos Labs will not ask you to download a messaging app for an interview or outlay your own money to get started as an employee. If this sounds like your interaction with people claiming to be with Altos, it is not legitimate and has nothing to do with Altos. Learn more about a common job scam at &lt;a href=&quot;https://www.linkedin.com/pulse/how-spot-avoid-online-job-scams-biron-clark/&quot; target=&quot;_blank&quot;&gt;https://www.linkedin.com/pulse/how-spot-avoid-online-job-scams-biron-clark/&lt;/a&gt;&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;

General Interest: Join Our Talent Community (Cambridge, UK)

Altos Labs

Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapi...

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Moderna

Commonwealth Fusion Systems (CFS) is an American company founded in 2018 aiming to build a compact nuclear fusion power plant based on the ARC tokamak reactor concept. The company is based in Cambridge, Massachusetts, and is a spin-off of the Massachusetts Institute of Technology (MIT). CFS is a member of the United States Department of Energy’s INFUSE public-private knowledge innovation scheme, with Princeton Plasma Physics Laboratory and the MIT's Plasma Science and Fusion Center.

Commonwealth Fusion Systems

EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. Headquartered in Cambridge, Massachusetts, the company is backed by GV, ARCH Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, Nextech, and Arboretum Ventures.

EQRx

ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.

ElevateBio

Cogent Biosciences, Inc. operates as a biotechnology company. The Company focuses on development and commercialization of solutions to treat cancers, autoimmune conditions, and rare diseases. Cogent Biosciences serves patients worldwide.

Unum Therapeutics

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.

Centessa Pharmaceuticals

Inari is a biotech seed company that embraces diversity in every aspect of its business to drive innovation and help build a new food system. Our technology matches the complexity of nature using predictive design and multiplex gene editing to unlock the full potential of seed. We are always innovating, pushing the boundaries of what’s possible. Our SEEDesign platform is our point of distinction, using unsurpassed technology to enhance any crop for any geography to develop step-change products with a clear go-to-market approach.

Inari

Cambridge Mobile Telematics Inc. provides software solutions. The Company designs and develops telematics and analytics software for extracting actionable insights on driving behaviors and vehicle dynamics. Cambridge Mobile Telematics serves customers in the United States.

Cambridge Mobile Telematics

Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Laronde

Devo is the leading Data Operations Platform for the digital enterprise. Devo delivers real-time business value from analytics on streaming and historical data to help Fortune 1000 enterprises drive sustained performance and growth. The Devo Data Operations Platform collects, enhances and analyzes machine, business, and operational data from across the enterprise. Devo provides real-time analytics and insight for IT operations, security analytics, business analytics, customer insight and log management for the world’s leading organizations.

Devo

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.

EGenesis

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.
We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.

Prime Medicine

A cancer diagnosis is something no one wants to hear. Too often, cancer is detected late, once it has spread and treatment options are limited. But cancer can be more effectively treated with an intent to cure if caught in the earlier stages. At Thrive, an Exact Sciences Company, our goal is to transform this outlook: to catch cancer earlier, including several with no screening options today, to improve patient outcomes. We are developing a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages. Our approach goes beyond a cancer diagnosis. We are developing a platform that will serve as a resource to help patients and their families maneuver the often confusing and overwhelming path that follows a cancer diagnosis.

Thrive Earlier Detection

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.

Be Biopharma

Obsidian Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops adoptive cell therapies for the treatment of patient with cancer diseases. Obsidian Therapeutics serves customers in the State of Massachusetts.

Obsidian Therapeutics

Bicara Therapeutics, a wholly-owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. which accelerates the development of cutting-edge therapies for cancer. Synergies between the scientific teams in Boston and Bengaluru will pioneer rapid and cost-effective breakthrough innovation.

Bicara Therapeutics

Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

Arbor Biotechnologies

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.

ReNAgade Therapeutics

Liquid AI is a developer of AI applications that help improve human experience. It focuses on researching and developing tools that use artificial intelligence to improve creative workflows and help clients manage their workflow efficiently.

Liquid AI

Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

Aviceda Therapeutics

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.

Orbital Therapeutics

Superpedestrian, Inc. manufactures electronic bicycle accessories. The Company designs and produces equipment for the storage of energy and assistance in bicycle riding.

Superpedestrian

Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.

Ring Therapeutics

MIT-IBM Watson AI Lab is an artificial intelligence research facility where IBM researchers and MIT students and faculty will work side by side to conduct advanced AI research.

MIT-IBM Watson AI Lab

MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.

Cambridge Jobs

Altos Labs

Companies headquartered in Cambridge

Tech Jobs by City

💸 Investors

💻 Job Types

📚 Popular Blog Posts